Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Ignyta Inc patents


Recent patent applications related to Ignyta Inc. Ignyta Inc is listed as an Agent/Assignee. Note: Ignyta Inc may have other listings under different names/spellings. We're not affiliated with Ignyta Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "I" | Ignyta Inc-related inventors


Compositions and methods for treating patients with rtk mutant cells

Disclosed herein are compositions and methods for treating cancer patients who have been previously treated with one or more chemotherapeutic agents and have developed at least partial resistance to such chemotherapeutic agents. Also disclosed are methods for selecting compounds suitable for treatment of cancer in a patient who has become resistant to an inhibitor of a receptor tyrosine kinase (rtk).. ... Ignyta Inc

Pyrazolo[1,5-a]pyridine derivatives and methods of their use

The invention is directed to pyrazolo[1,5-a]pyridine derivatives and their use as axl and c-met kinase inhibitors.. . ... Ignyta Inc

Bendamustine derivatives and methods of using same

The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.. . ... Ignyta Inc

Multiplexed immunohistochemistry assays for diagnosis and treatment of cancer

The present disclosure generally relates to methods and compositions for identifying and/or treating cancer patients harboring one or more molecular alterations in clinically important biomarkers, preferably in multiplexed assays, such that multiple biomarkers can be assayed simultaneously. In one embodiment, the disclosure relates to methods for rapid screening large populations of biological samples by using a high-throughput multiplexed assay to assess relative prevalence of multiple indications, optionally followed by a second analytical assay with higher sensitivity and specificity.. ... Ignyta Inc

Solid state forms of a quinazoline derivative and its use as a braf inhibitor

. . This application relates to various salts and solid state forms of compound (i). This application also relates to pharmaceutical compositions and therapeutic uses of these materials and compositions.. ... Ignyta Inc

Bendamustine derivatives and methods of using same

The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.. . ... Ignyta Inc

Combinations for the treatment of neuroblastoma

Disclosed are methods of treating neuroblastoma in a cancer patient by administration of a trk inhibitor in combination with one more chemotherapeutic agents. Also disclosed are pharmaceutical compositions comprising a trk inhibitor and one or more chemotherapeutic agents.. ... Ignyta Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Ignyta Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Ignyta Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###